Several studies reported that the hs‐CRP level, which is a known CVD risk factor, is correlated with liver histology in NAFLD patients (Kumar et al., 2020; Lee et al., 2017). Here, MAP3K14 is linked to metabolic dysfunction-associated steatotic liver disease.